Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IDEAYA Biosciences (IDYA) Other Non-Current Liabilities: 2019-2021

Historic Other Non-Current Liabilities for IDEAYA Biosciences (IDYA) over the last 3 years, with Sep 2021 value amounting to $6,000.

  • IDEAYA Biosciences' Other Non-Current Liabilities fell 50.00% to $6,000 in Q3 2021 from the same period last year, while for Sep 2021 it was $6,000, marking a year-over-year decrease of 50.00%. This contributed to the annual value of $12,000 for FY2020, which is 64.71% down from last year.
  • As of Q3 2021, IDEAYA Biosciences' Other Non-Current Liabilities stood at $6,000, which was down 0.00% from $6,000 recorded in Q2 2021.
  • IDEAYA Biosciences' Other Non-Current Liabilities' 5-year high stood at $60,000 during Q2 2019, with a 5-year trough of $6,000 in Q1 2021.
  • Its 3-year average for Other Non-Current Liabilities is $22,500, with a median of $14,000 in 2020.
  • Data for IDEAYA Biosciences' Other Non-Current Liabilities shows a maximum YoY slumped of 76.92% (in 2020) over the last 5 years.
  • Over the past 3 years, IDEAYA Biosciences' Other Non-Current Liabilities (Quarterly) stood at $34,000 in 2019, then slumped by 64.71% to $12,000 in 2020, then slumped by 50.00% to $6,000 in 2021.
  • Its Other Non-Current Liabilities stands at $6,000 for Q3 2021, versus $6,000 for Q2 2021 and $6,000 for Q1 2021.